CoChat

The DOI matches its Crossref record; 56 of the 57 references it cites were found in a registry or an index.

Comparative efficacy and acceptability of first-generation and second-generation antidepressants in the acute treatment of major depression: protocol for a network meta-analysis

Open access

Abstract

Introduction: Many antidepressants are indicated for the treatment of major depression. Two network meta-analyses have provided the most comprehensive assessments to date, accounting for both direct and indirect comparisons; however, these reported conflicting interpretation of results. Here, we present a protocol for a systematic review and network meta-analysis aimed at updating the evidence base and comparing all second-generation as well as selected first-generation antidepressants in terms of efficacy and acceptability in the acute treatment of major depression. Methods and analysis: We will include all randomised controlled trials reported as double-blind and comparing one active drug with another or with placebo in the acute phase treatment of major depression in adults. We are interested in comparing the following active agents: agomelatine, amitriptyline, bupropion, citalopram, clomipramine, desvenlafaxine, duloxetine, escitalopram, fluoxetine, fluvoxamine, levomilnacipran, milnacipran, mirtazapine, nefazodone, paroxetine, reboxetine, sertraline, trazodone, venlafaxine, vilazodone and vortioxetine. The main outcomes will be the proportion of patients who responded to or dropped out of the allocated treatment. Published and unpublished studies will be sought through relevant database searches, trial registries and websites; all reference selection and data extraction will be conducted by at least two independent reviewers. We will conduct a random effects network meta-analysis to synthesise all evidence for each outcome and obtain a comprehensive ranking of all treatments. To rank the various treatments for each outcome, we will use the surface under the cumulative ranking curve and the mean ranks. We will employ local as well as global methods to evaluate consistency. We will fit our model in a Bayesian framework using OpenBUGS, and produce results and various checks in Stata and R. We will also assess the quality of evidence contributing to network estimates of the main outcomes with the GRADE framework. Ethics and dissemination: This review does not require ethical approval. PROSPERO registration number: CRD42012002291.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1136/bmjopen-2015-010919

Cites

56 of 57 references verified1 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Network of all possible pairwise comparisons between the eligible interventions.
Figure 1 Network of all possible pairwise comparisons between the eligible interventions.CC BY-NC · PubMed Central
Figure 2 Decision-tree for data extraction of continuous efficacy outcome. HDRS: Hamilton Depression Rating Scale; MADRS: Montgomery-Åsberg Depression Rating Scale.
Figure 2 Decision-tree for data extraction of continuous efficacy outcome. HDRS: Hamilton Depression Rating Scale; MADRS: Montgomery-Åsberg Depression Rating Scale.CC BY-NC · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 57 references

Research works printed but not linked: 1

  1. 10.1037/0022-006X.60.5.664 · DOI · Paper page

Cited by

See all 214

Metadata

Authors
Furukawa, T. A., Salanti, G., Atkinson, L. Z., Leucht, S., Ruhe, H. G., Turner, E. H., Chaimani, A., Ogawa, Y., Takeshima, N., Hayasaka, Y., Imai, H., Shinohara, K., Suganuma, A., Watanabe, N., Stockton, S., Geddes, J. R., & Cipriani, A.
Affiliations
  • Kyoto University (JP)
  • University of Bern (CH)
  • University of Oxford (GB)
  • Technical University of Munich (DE)
  • Department of Psychiatry, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands
  • Oregon Health & Science University (US)
  • University of Ioannina (GR)
  • Oxford Health NHS Foundation Trust (GB)
Corresponding author
Cipriani, Andrea
Venue
BMJ Open
Publisher
BMJ
Published
2016-07
Volume
6
Issue
7
Pages
e010919
ISSN
2044-6055 (ISSN-L)
OpenAlex
W2468146111
Cited by
214
References
55
Citations by year
2026: 10 · 2025: 19 · 2024: 18 · 2023: 12 · 2022: 23 · 2021: 44 · 2020: 31 · 2019: 20 · 2018: 24 · 2017: 10 · 2016: 3
FWCI
15.36
Type
journal article
Language
en
Open access
Licence
cc-by-nc
Locations
  • BMJ Open (publishedVersion, cc-by-nc)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by-nc)
  • PubMed Central (publishedVersion, cc-by-nc)
  • PubMed (publishedVersion)
  • Pure Amsterdam UMC (publishedVersion, other-oa)
  • Institutional Repositories DataBase (IRDB) (submittedVersion, cc-by-nc)
  • Data Archiving and Networked Services (DANS) (submittedVersion)
  • BORIS (University Library Bern) (submittedVersion, cc-by-nc)
  • mediaTUM – the media and publications repository of the Technical University Munich (Technical University Munich) (submittedVersion)
  • HighWire Press Open Archive (submittedVersion)
  • University of Groningen research database (University of Groningen / Centre for Information Technology) (submittedVersion, cc-by-nc)
  • Kyoto University Research Information Repository (Kyoto University) (submittedVersion, cc-by-nc)
  • Open Access CRIS of the University of Bern
Funders
  • Bristol-Myers Squibb
  • Eli Lilly and Company
  • Pfizer
  • AstraZeneca
  • GlaxoSmithKline
  • Sanofi
  • Teva Pharmaceutical Industries
  • National Institute for Health and Care Research
  • Servier
  • H. Lundbeck A/S
  • AOP Orphan
Topics
  • Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
  • Health Sciences › Medicine › Psychiatry and Mental health › Mental Health Treatment and Access
  • Social Sciences › Psychology › Clinical Psychology › Psychotherapy Techniques and Applications
Keywords
major depressive disorder, antidepressants, second-generation antidepressants, acute treatment, treatment efficacy, treatment acceptability, treatment response, treatment discontinuation, drug comparison, surface under the cumulative ranking curve
MeSH terms
Network Meta-Analysis as Topic, Systematic Reviews as Topic, Antidepressive Agents, Bayes Theorem, Major Depressive Disorder, Humans, Treatment Outcome, Antidepressive Agents, Second-Generation

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Comparative efficacy and acceptability of first-generation and second-generation antidepressants in the acute treatment of major depression: protocol for a network meta-analysis. https://app.cochat.ai/papers/10.1136/bmjopen-2015-010919
The paper
Furukawa, T. A., Salanti, G., Atkinson, L. Z., Leucht, S., Ruhe, H. G., Turner, E. H., Chaimani, A., Ogawa, Y., Takeshima, N., Hayasaka, Y., Imai, H., Shinohara, K., Suganuma, A., Watanabe, N., Stockton, S., Geddes, J. R., & Cipriani, A. (2016). Comparative efficacy and acceptability of first-generation and second-generation antidepressants in the acute treatment of major depression: protocol for a network meta-analysis. BMJ Open. https://doi.org/10.1136/bmjopen-2015-010919

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.